COPENHAGEN, Oct 8 (Reuters) – An experimental Novartis
pill given with an older drug kept advanced breast
cancer in check far longer than standard treatment alone,
putting it on track to challenge…
The post Novartis challenges Pfizer with strong breast cancer drug data appeared first on NASDAQ.